DE69301742T2 - Darreichungsformen mit verlaengerter Wirkstoffreigabe - Google Patents

Darreichungsformen mit verlaengerter Wirkstoffreigabe

Info

Publication number
DE69301742T2
DE69301742T2 DE69301742T DE69301742T DE69301742T2 DE 69301742 T2 DE69301742 T2 DE 69301742T2 DE 69301742 T DE69301742 T DE 69301742T DE 69301742 T DE69301742 T DE 69301742T DE 69301742 T2 DE69301742 T2 DE 69301742T2
Authority
DE
Germany
Prior art keywords
dosage forms
weight
active ingredient
extended release
calcium antagonist
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69301742T
Other languages
English (en)
Other versions
DE69301742D1 (de
Inventor
Sabine Compassi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siegfried AG
Original Assignee
Siegfried Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siegfried Pharma AG filed Critical Siegfried Pharma AG
Publication of DE69301742D1 publication Critical patent/DE69301742D1/de
Application granted granted Critical
Publication of DE69301742T2 publication Critical patent/DE69301742T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
DE69301742T 1992-02-17 1993-02-03 Darreichungsformen mit verlaengerter Wirkstoffreigabe Expired - Fee Related DE69301742T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH46992 1992-02-17

Publications (2)

Publication Number Publication Date
DE69301742D1 DE69301742D1 (de) 1996-04-18
DE69301742T2 true DE69301742T2 (de) 1996-08-14

Family

ID=4187725

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69301742T Expired - Fee Related DE69301742T2 (de) 1992-02-17 1993-02-03 Darreichungsformen mit verlaengerter Wirkstoffreigabe

Country Status (6)

Country Link
EP (1) EP0557244B1 (de)
AT (1) ATE135214T1 (de)
DE (1) DE69301742T2 (de)
DK (1) DK0557244T3 (de)
ES (1) ES2084478T3 (de)
GR (1) GR3019314T3 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5393765A (en) * 1993-12-13 1995-02-28 Hoffmann-La Roche Inc. Pharmaceutical compositions with constant erosion volume for zero order controlled release
NZ270439A (en) * 1995-02-02 1996-04-26 Bernard Charles Sherman Solid slow release pharmaceutical composition: carrier is polyethylene glycol and hydrophilic gel-forming polymer
NZ286451A (en) * 1996-04-24 1998-04-27 Bernard Charles Sherman Controlled release pharmaceutical composition containing granules comprising drug, water-insoluble polymer and meltable carrier
FR2901611B1 (fr) * 2006-05-24 2009-01-16 Airbus France Sas Dispositif de controle non destructif d'une piece par analyse de distribution du champ magnetique de fuite

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4571333A (en) * 1983-06-14 1986-02-18 Syntex (U.S.A.) Inc. Controlled release naproxen and naproxen sodium tablets
JPS6038322A (ja) * 1983-08-11 1985-02-27 Fujisawa Pharmaceut Co Ltd ジヒドロピリジンａ物質含有易溶性固形製剤
JPS6124516A (ja) * 1984-07-12 1986-02-03 Fujisawa Pharmaceut Co Ltd 持続性錠剤
IT1187751B (it) * 1985-10-15 1987-12-23 Eurand Spa Procedimento per la preparazione di formulazioni solidi di nifedipina ad elevata biodisponibilita' e ad effetto prolungato e formulazioni cosi' ottenute
IE59540B1 (en) * 1987-01-09 1994-03-09 Elan Corp Sustained release capsule or tablet formulation
GB8722306D0 (en) * 1987-09-22 1987-10-28 Aps Research Ltd Sustained-release formulation
SI8810082A8 (en) * 1988-01-18 1995-12-31 Lek Tovarna Farmacevtskih Process for preparing new inclusion complex of nicardipine or its hydrochloride with beta-cyclodextrine
DE3814532A1 (de) * 1988-04-29 1989-11-09 Bayer Ag Dhp-retard-zubereitung

Also Published As

Publication number Publication date
ATE135214T1 (de) 1996-03-15
DE69301742D1 (de) 1996-04-18
DK0557244T3 (da) 1996-04-01
ES2084478T3 (es) 1996-05-01
EP0557244B1 (de) 1996-03-13
GR3019314T3 (en) 1996-06-30
EP0557244A1 (de) 1993-08-25

Similar Documents

Publication Publication Date Title
RU93004469A (ru) Формы дозирования, обеспечивающие продленное выделение активного ингредиента
GEP20012549B (en) Pharmaceutical Composition Containing Sumatriptan
EP2103303A3 (de) Tramadolhaltige Formulierung mit gesteuerter Freisetzung
ES2191034T3 (es) Formulaciones de liberacion controlada para la liberacion de metoprolol durante 24 horas.
CA2131350A1 (en) Sustained release drug formulation containing a tramadol salt
DE69523438T2 (de) Orale metoprolol-dosisform des typs "einmal täglich"
WO1997012583A3 (en) Stable compositions containing n-propargyl-1-aminoindan
CA2240329A1 (en) Improved delivery of multiple doses of medications
NZ311145A (en) Controlled release formulations containing a poorly soluble drug in a solid dispersion with a hydrophilic poloxamer
MY125662A (en) Pharmaceutical formulations containing darifenacin
NO20014724D0 (no) Pregelatinisert stivelse i en formulering med regulert frigivning
MX9300664A (es) Formas de dosis farmaceuticas que contienen liberacion prolongada de ingrediente activo.
HU0200688D0 (en) Pharmaceutical formulations with improved release containing solid salts of racemic thioctic acid
FI933274A0 (fi) Tvaerbundna, kvaevehaltiga vinylkopolymerer, foerfarande foer framstaellning av dessa samt anvaendning av dessa
DE69622739D1 (de) Pharmazeutische zubereitung mit schneller freisetzung
ATE253354T1 (de) Kapseln mit loratadin und pseudoephedrin enthaltenden zusammensetzungen
DE69723024D1 (de) Pharmazeutische Zusammensetzungen mit kontrollierter Freisetzung zur oralen Verabreichung enthaltend Nifedipin als Wirkstoff
DE69301742T2 (de) Darreichungsformen mit verlaengerter Wirkstoffreigabe
ATE136778T1 (de) Oral anzuwendende arzneimittel dapiprazol enthaltend
EP0761209A3 (de) Ranitidinformulierungen mit gesteuerter Freisetzung
CA2187153A1 (en) Effervescent pharmaceutical formulations containing controlled release biodegradable microcapsules

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: SIEGFRIED CMS AG, ZOFINGEN, CH

8327 Change in the person/name/address of the patent owner

Owner name: SIEGFRIED AG, ZOFINGEN, CH

8328 Change in the person/name/address of the agent

Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN

8328 Change in the person/name/address of the agent

Representative=s name: MAIWALD PATENTANWALTSGESELLSCHAFT MBH, 80335 MUENC

8339 Ceased/non-payment of the annual fee